BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36585530)

  • 21. Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus.
    Zeng Y; Lin Q; Yu L; Wang X; Lin Y; Zhang Y; Yan S; Lu X; Li Y; Li W; Xiao Y
    BMC Immunol; 2021 Dec; 22(1):82. PubMed ID: 34961474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
    Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
    Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus.
    Jin L; Bai R; Zhou J; Shi W; Xu L; Sheng J; Peng H; Jin Y; Yuan H
    Med Sci Monit Basic Res; 2018 Oct; 24():168-176. PubMed ID: 30348938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis.
    Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF
    Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1), a novel disease activity predictive biomarker of systemic lupus erythematosus.
    Ahn SS; Hong SH; Park Y; Jung SM; Song JJ; Park YB; Lee SW; Park SG
    Clin Exp Rheumatol; 2018; 36(4):533-539. PubMed ID: 29352840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
    Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus.
    Kim JW; Jung JY; Lee SW; Baek WY; Kim HA; Suh CH
    Front Immunol; 2022; 13():886209. PubMed ID: 35529863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-DFS70 antibodies in systemic lupus erythematosus: Prevalence in a large Chinese cohort and an unexpected association with anti-dsDNA antibodies by a long-term follow-up.
    Dai Y; Li E; Chen D; Niu X; Wang Z; Lu L; Zheng B
    Front Immunol; 2022; 13():913714. PubMed ID: 36189276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
    Matsuoka N; Fujita Y; Temmoku J; Furuya MY; Asano T; Sato S; Matsumoto H; Kobayashi H; Watanabe H; Suzuki E; Kozuru H; Yastuhashi H; Migita K
    PLoS One; 2020; 15(1):e0227069. PubMed ID: 31986153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.
    Pruzanski W; Goulding NJ; Flower RJ; Gladman DD; Urowitz MB; Goodman PJ; Scott KF; Vadas P
    J Rheumatol; 1994 Feb; 21(2):252-7. PubMed ID: 8182633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity.
    Zeng Y; Zhang Y; Lin Y; Wang X; Chen Q; Huang Q; Wang J; Jiang L; Xiao Y
    Clin Exp Med; 2021 Nov; 21(4):611-619. PubMed ID: 33844093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum interleukin-33 (IL-33) in children with active systemic lupus erythematosus: A cross-sectional study.
    Abd-Elazeem RI; Abdelnabi HH; Hegab DS; Mohamed WS; Ameen TE
    Egypt J Immunol; 2022 Oct; 29(4):148-155. PubMed ID: 36208043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta-analysis.
    Guan SY; Cai HY; Wang P; Lv TT; Liu LN; Mao YM; Zhao CN; Wu Q; Dan YL; Sam NB; Wang DG; Pan HF
    Int J Rheum Dis; 2019 Oct; 22(10):1803-1813. PubMed ID: 31468723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring serum levels of high-mobility group box 1 by enzyme-linked immunosorbent assay does not identify bacterial infections in patients with systemic lupus erythematosus.
    Tang KT; Hsieh TY; Chen YM; Hsieh CW; Chen YH; Chen DY
    Lupus; 2014 Aug; 23(9):926-34. PubMed ID: 24704776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α.
    Mathian A; Mouries-Martin S; Dorgham K; Devilliers H; Barnabei L; Ben Salah E; Cohen-Aubart F; Garrido Castillo L; Haroche J; Hie M; Pineton de Chambrun M; Miyara M; Sterlin D; Pha M; Lê Thi Huong D; Rieux-Laucat F; Rozenberg F; Gorochov G; Amoura Z
    Arthritis Rheumatol; 2019 May; 71(5):756-765. PubMed ID: 30507062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low serum uromodulin levels and their association with lupus flares.
    David BL; Ivan GJ; Emilio PE; Daniela MJ; Betsabe CH; Luisa VM; Selene FN; Guadalupe AEA; Miriam SA; Alfredo C; Arturo NC; Mercedes HD; German CE; Gonzalez-Lopez L
    PLoS One; 2022; 17(10):e0276481. PubMed ID: 36301848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship of serum 25- hydroxy vitamin D and systemic lupus erythematosus].
    Zou JM; Wu LJ; Luo CN; Shi YM; Wu X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):938-941. PubMed ID: 34650298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus.
    Kamel SM; Abdel Azeem Abd Elazeem MEMI; Mohamed RA; Kamel MM; Abdel Aleem Abdelaleem EA
    Int J Immunopathol Pharmacol; 2023; 37():3946320231154988. PubMed ID: 36718110
    [No Abstract]   [Full Text] [Related]  

  • 39. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity.
    Amoura Z; Piette JC; Chabre H; Cacoub P; Papo T; Wechsler B; Bach JF; Koutouzov S
    Arthritis Rheum; 1997 Dec; 40(12):2217-25. PubMed ID: 9416860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Increased serum C-C chemokine ligand 19 levels correlated with B cell abnormalities in systemic lupus erythematosus].
    Liu HJ; Shi LJ; Hu FL; Yao HH; Li ZG; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):829-834. PubMed ID: 29045964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.